• Japanese
  • Korean
  • Chinese
Cover Image

Myocardial Ischemia Global Clinical Trials Review, H2, 2014

GlobalData's clinical trial report, "Myocardial Ischemia Global Clinical Trials Review, H2, 2014" provides data on the Myocardial Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myocardial Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myocardial Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Myocardial Ischemia
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Myocardial Ischemia
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Myocardial Ischemia Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Myocardial Ischemia
    • Jun 12, 2014: Cardium To Announce Interim Results Of Generx Angiogenic Gene Therapy Phase 3 Clinical Study At The 2014 BIO International Convention
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Gilead Sciences, Inc.
      • Clinical Trial Overview of Gilead Sciences, Inc.
      • Abbott Laboratories
      • Clinical Trial Overview of Abbott Laboratories
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Medicure Inc.
      • Clinical Trial Overview of Medicure Inc.
      • Cytori Therapeutics, Inc.
      • Clinical Trial Overview of Cytori Therapeutics, Inc.
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
    • Clinical Trial Overview of Top Institutes / Government
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Imperial College London
      • Clinical Trial Overview of Imperial College London
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Hartford Hospital
      • Clinical Trial Overview of Hartford Hospital
      • Erasmus MC
      • Clinical Trial Overview of Erasmus MC
      • Ottawa Hospital Research Institute
      • Clinical Trial Overview of Ottawa Hospital Research Institute
      • Flinders Medical Centre
      • Clinical Trial Overview of Flinders Medical Centre
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Region, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Myocardial Ischemia Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Myocardial Ischemia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Myocardial Ischemia Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicure Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytori Therapeutics, Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hartford Hospital, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Flinders Medical Centre, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*

List of Figures

  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Myocardial Ischemia to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Myocardial Ischemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Myocardial Ischemia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Show More
Pricing